These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15088900)

  • 1. Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer.
    Lahme S; Bichler KH; Feil G; Zumbrägel A; Götz T
    Adv Exp Med Biol; 2003; 539(Pt A):111-9. PubMed ID: 15088900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer.
    Lahme S; Bichler KH; Feil G; Krause S
    Urol Int; 2001; 66(2):72-7. PubMed ID: 11223747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
    Lekili M; Sener E; Demir MA; Temeltaş G; Müezzinoğlu T; Büyüksu C
    Urol Res; 2004 May; 32(2):124-8. PubMed ID: 14685796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMP 22, BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study.
    Gutiérrez Baños JL; Rebollo Rodrigo MH; Antolín Juárez FM; Martín García B
    Urol Int; 2001; 66(4):185-90. PubMed ID: 11385303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NMP-22 in the diagnosis of bladder cancer].
    Gutiérrez Baños JL; Rebollo Rodrigo MH; Antolín Juárez F; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; Del Valle Schaan JI; Roca Edreira A; De Diego Rodríguez E; Rado Velázquez MA; Hernández Castrillo A
    Actas Urol Esp; 2000 Oct; 24(9):715-20. PubMed ID: 11132442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
    Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of urinary NMP-22 combined with urine cytology in follow-up surveillance of recurring superficial bladder urothelial carcinoma.
    Mansoor I; Calam RR; Al-Khafaji B
    Anal Quant Cytol Histol; 2008 Feb; 30(1):25-32. PubMed ID: 18459584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
    Gupta NP; Sharma N; Kumar R
    Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.
    Tsui KH; Chen SM; Wang TM; Juang HH; Chen CL; Sun GH; Chang PL
    Asian J Androl; 2007 Sep; 9(5):711-5. PubMed ID: 17712491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
    Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
    Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the nuclear matrix protein 22 Bladder Chek test™ in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer.
    Balci M; Tuncel A; Guzel O; Aslan Y; Sezgin T; Bilgin O; Senel C; Atan A
    Int Urol Nephrol; 2015 Mar; 47(3):473-7. PubMed ID: 25649031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
    Landman J; Chang Y; Kavaler E; Droller MJ; Liu BC
    Urology; 1998 Sep; 52(3):398-402. PubMed ID: 9730450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study between cystoscopy, urinary cytology, NMP-22 and a new method, bladder chek, in the follow-up of superficial bladder cell carcinoma].
    Aguilera Tubet C; Gutiérrez Baños JL; Antolín Juárez F; Rebollo Rodrigo MH; Portillo Martín JA; Ruiz Izquierdo F; Ballestero Diego R; Martín García B
    Actas Urol Esp; 2005 Mar; 29(3):252-6. PubMed ID: 15945249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
    Pichler R; Tulchiner G; Fritz J; Schaefer G; Horninger W; Heidegger I
    Int J Med Sci; 2017; 14(9):811-819. PubMed ID: 28824318
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test.
    Del Nero A; Esposito N; Currò A; Biasoni D; Montanari E; Mangiarotti B; Trinchieri A; Zanetti G; Serrago MP; Pisani E
    Eur Urol; 1999 Feb; 35(2):93-7. PubMed ID: 9933801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study.
    Schlake A; Crispen PL; Cap AP; Atkinson T; Davenport D; Preston DM
    Can J Urol; 2012 Aug; 19(4):6345-50. PubMed ID: 22892257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study comparing various noninvasive methods of detecting bladder cancer in urine.
    Saad A; Hanbury DC; McNicholas TA; Boustead GB; Morgan S; Woodman AC
    BJU Int; 2002 Mar; 89(4):369-73. PubMed ID: 11872026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.
    Coskuner E; Cevik I; Ozkan A; Dillioglugil O; Akdas A
    Int Urol Nephrol; 2012 Jun; 44(3):793-8. PubMed ID: 22371126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.